|
|
Wednesday, March 17
|
| 11:00 AM-12:30 PM |
|
| Special Session |
The Endocrine System in the COVID Pandemic |
|
Day 1
|
Saturday, March 20, 2021
|
| 11:00 AM-12:15 PM |
|
| Presidential Plenary
|
 The Impact of Basic Tissue Engineering and the Basic Biology of GPCRs in Emerging Therapies
|
| 11:15 AM-12:00 PM |
|
| Meet the Professor
|
 Closing the Loop With Pump and Sensor Communication in Diabetes Mellitus: How to Digest Data and Develop Treatment Recommendations During a Clinic Visit |
|
|
Pseudoacromegaly Syndromes
|
|
|
Challenging Cases in Bone and Mineral Disease
|
| |
Evaluation of Female Fertility: Antimullerian Hormone and Ovarian Reserve Testing
|
| 11:15 AM-12:15 PM |
|
| Oral Abstract |
Emerging Endocrine Therapies Across the Lifespan |
| 12:30-1:30 PM |
|
| Endocrine Debate
|
Using SGLT2 Inhibitors in Patients With T1DM
|
| 12:30-2:00 PM |
|
| Symposium
|
You've Been Cured of Thyroid Cancer... Now What?
|
| |
Treatment Options in Osteoporosis Across the Spectrum of Fracture Risk
|
| |
 Ice Ice Baby: Fertility Preservation and Restoration
|
| |
 Beyond the Genetics of Primary Aldosteronism: What's Next?
|
| |
Molecular Drivers of Aggressive Endocrine Neoplasms
|
| 2:15-3:15 PM |
|
| Master Clinician
|
Thyroid Nodule: Whack It, Zap It, or Leave It Alone?
|
|
Oral Abstract
|
Therapeutic Trials and Prognostic Markers for Adrenal Diseases
|
| |
Pediatric Endocrinology: Growth and Development
|
| |
Reciprocal Effects of Ovarian and Metabolic Dysfunction
|
| |
 Thyroid Cancer and Autoimmunity
|
| Professional Development
|
Keys to Education Excellence: Innovative and Effective Teaching Strategies
|
| 3:30-4:15 PM |
|
| Presidential Plenary |
Big Data and the Future of Endocrine Research |
| Special Scientific
|
 Meet the Scientist: Drugs, Steroids, and Cancer: Bridging the Worlds of Endocrinology, Metabolism, and Oncology
|
| |
Meet the Patient: Rare Bone Disease
|
|
Meet the Professor
|
 Complexities in the Diagnosis and Treatment of Cushing Syndrome
|
| |
Evaluation of Female Fertility: Antimullerian Hormone and Ovarian Reserve Testing |
| 3:30-4:30 PM |
|
| Oral Abstract |
Diabetes and Metabolic Disease in Women |
| |
The Relationship Between COVID-19 and Endocrinology
|
| 3:30-4:30 PM |
|
| Product Theater |
Acromegaly and the Role of Oral Octreotide (MYCAPSSA) in its Management
|
| |
Recent Advances in the Treatment of Cushing's Disease
|
|
Hypercortisolism: Emerging Clinical Insights |
| 5:30-7:00 PM |
|
| Ancillary Symposia |
Ushering in a New Era of Sustainable Weight Loss with Incretin-Based Therapies |
| |
Overcoming Pitfalls to Optimize Cushing’s Disease Diagnosis and Management |
|
Day 2
|
Sunday, March 21, 2021
|
| 8:30-10:00 AM |
|
| Ancillary Symposia |
Plugging In To Improved Patient Care with Diabetes Technology |
| 10:00-10:45 AM |
|
| Professional Development |
Virtual Speed Mentoring for Early Career Professionals |
| |
Laureate Awardee Recognition |
| 10:00-10:55 AM |
|
| Guided Poster Tours |
Nuclear Receptors and Signaling |
| 10:10-10:55 AM |
|
| Product Theater |
FreeStyle Libre 2 System and LibreView - Remote Glucose Monitoring and Telemedicine Practices |
| |
Co-management With TEPEZZA® (teprotumumab-trbw) |
| |
CPP Updates and Fensolvi® Clinical & Product Brief |
| 11:00-11:45 AM |
|
| Plenary |
A Deep Dive Into Development and Cancer |
| Special Scientific
|
Meet the Scientist: Bringing Drugs From the Lab to the Patient
|
|
|
Clark T. Sawin Memorial History of Endocrinology Lecture: The Lessons Learned from the History of Identifying and Addressing Health Disparities in Endocrinology and Diabetes
|
|
Meet the Professor
|
Selection, Dosing, and Monitoring of Steroid Replacement in the Patient With Adrenal Failure
|
|
|
When Thyroid Function Tests Don't Make Sense
|
| |
Detection and Management of Abuse of Androgenic Performance-Enhancing Drugs
|
| 12:15-1:45 PM |
|
| Master Clinician
|
Genes and Surveillance for Patients and Family With Familial Pheochromocytoma and Paraganglioma Syndromes
|
|
Professional Development
|
Reducing the Bias: Ways Perceptions Influence Behavior and How We Can Do Better
|
|
Symposium
|
Transgender Care: A Comprehensive Assessment for a Multi-Faceted Condition
|
| |
Structural Determinants of Nuclear Receptor Function
|
| |
Data Overload — How to Integrate Diabetes Technology Into Your Research and Practice
|
| |
Intra- and Extracellular Vesicle Trafficking at the Maternal-Fetal Interface Impacts Pregnancy Outcomes
|
| 2:00-3:00 PM |
|
| Endocrine Debate
|
Does the Treatment of Hyperthyroidism Lead to Cancer?
|
|
Oral Abstract
|
Wide Spectrum of Translational Adrenal Research
|
| |
Improving Diabetes Care: Hospital Discharge, Complications, and Novel Insulin Therapy
|
| |
Hot Topics in Pediatric Endocrinology
|
| |
Steroid Receptors in Development and Disease
|
| |
Emerging Mechanisms and Therapies in Endocrine-Related Tumor Biology
|
| 3:15-4:15 PM |
|
| Plenary
|
Bridging the Translational Divide: Successes in Bench to Bedside |
| 3:15-4:00 PM |
|
| Meet the Professor
|
A Little Help From My Friends: The Endocrinology-Dermatology Interface — How Do We Help Each Other?
|
| |
Youth-Onset Type 2 Diabetes Mellitus
|
| 3:15-4:45 PM |
|
| Symposium
|
Thinking Microscopes - Artificial Intelligence in Imaging Molecules, Cells and Tumors
|
| |
Do We Finally Have Useful Markers for Aggressive Adrenal Tumors?
|
| |
Nuclear Receptor Genomics and Epigenomics
|
| 4:45-5:30 PM |
|
Product Theater
|
The value of Early T1D Diagnosis and Beta-cell Preservation |
| |
Proven Results With GLP-1 Receptor Agonist Therapy in Adult Patients With T2D |
| 5:30-7:00 PM |
|
| Ancillary Symposia |
Clinical Pearls: Hot Topics in Osteoporosis |
| |
Acromegaly: Novel Therapeutic Options to Alleviate Treatment Burden and Improve Patient Quality of Life |
|
Day 3
|
Monday, March 22, 2021
|
| 8:30-10:00 AM |
|
| Ancillary Symposia |
Refining Strategies for the Management of Hypophosphatemic Bone Disease
|
| 10:00-10:55 AM |
|
| Professional Development |
Presentation of the 2021 Laureate Award Recipients |
| 10:00-10:55 AM |
|
| Guided Poster Tours |
Diabetes and Metabolism |
| |
Reproductive Endocrinology |
| 10:10-10:55 AM |
|
| Product Theater |
Power Up: The Power of Dexcom G6 integrated continuous glucose monitoring (iCGM)
|
|
Potential Mechanisms Responsible for the Effects of Incretins on Atherosclerosis |
| |
Daily Somatropin Therapy: Consequences Beyond Growth
|
| 11:00 AM-12:00 PM |
|
| Plenary |
What Does Your Gut Tell You? How the Microbiome Modulates Metabolism |
| 11:00-11:45 AM |
|
| Special Scientific |
Meet the Scientist: Examining the Chromatin Landscape
|
| Meet the Professor |
Diagnosis and Management of Endocrine Hypertension: Deciding Who To Screen for Genetic Causes |
|
|
A Little Help From My Friends: The Endocrinology-Oncology Interface — How Do We Help Each Other?
|
| |
Bone Turnover Markers in the Management of Osteoporosis |
| |
Dopamine Agonists: Risks, Adverse Effects, Surveillance, and Intervention |
| 12:15-1:15 PM |
|
| Endocrine Debate |
This House Believes that Following MEN1 Surveillance Guidelines Can Do More Harm than Good |
| 12:15-1:45 PM |
|
| Symposium |
New Regulators of IGF Function Across the Lifespan |
| |
Skeletal Consequences of Systemic Disease |
| |
How Do We Confront Disparities in Obesity and COVID-19 Treatment |
| |
Transcriptional Programming of Adipocyte Biology |
| Professional Development |
B2B Rising Stars Power Talks |
| 2:00-3:00 PM |
|
| Oral Abstract |
Novel Insights into the Regulation of Adipose Tissue Remodeling |
| |
Bone, From Bench to Bedside |
| |
Lipids and Steroids in Cardiovascular Disease |
| |
Impacts of Organ Crosstalk and Sex on Diabetes Phenotypes |
| |
Clinical Advances in Pituitary Diseases |
| |
Androgens Across Sex, Gender and the Lifespan |
| 3:15-4:00 PM |
|
| Meet the Professor |
What Pediatric Endocrinologists Need to Know About Dyslipidemia? |
| |
Medications Contributing to Weight Gain and Obesity
|
| 3:15-4:00 PM |
|
| Meet the Professor |
Using Clinical Trial Results to Optimize Patient Care: Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With GLP-1 Receptor |
| 3:15-4:45 PM |
|
| Symposium |
Genomic Approaches to Understanding Hormone-Dependent Cancer and Resistance |
| |
Inter-Tissue Communication: Sending the Right Message |
| |
Thyroid Hormone Effects on Development and Regeneration |
| 4:45-5:30 PM |
|
| Product Theater |
Hypothyroidism Uncovered: Emerging Strategies for Optimal Management of Hypothyroidism |
| |
Recent Concepts in Osteoporosis Management |
| |
VASCEPA® (icosapent ethyl): Elevating the Standard of Care |
| 5:30-7:00 PM |
|
| Ancillary Symposium |
Precision Management of Late Endocrine Effects in Cancer Survivors |
| |
100 Years of Innovation in Insulin Therapy |
|
Day 4
|
Tuesday, March 23, 2021
|
| 10:00-10:20 AM |
|
| |
Endocrine Society Annual Business Meeting |
| 10:00-10:55 AM |
|
| Guided Poster Tours |
Nuclear Receptors and Signaling |
| 11:00 AM-12:00 PM |
|
| Plenary |
Treating Type 2 Diabetes: New Approaches for an Old Foe |
| Oral Abstract |
Environmental Endocrine Disruption in Development and Disease |
| 11:00-11:45 AM |
|
| Meet the Professor
|
Management of Pituitary Hormone Replacement Through Transition From Adolescence to Young Adulthood |
| |
Management of Thyroid Dysfunction Before and During Pregnancy |
| |
When Should You Order Advanced Lipoprotein Testing? |
| |
What Is the Ideal Vitamin D Level and Dosage for All Circumstances? |
| 12:15-1:45 PM |
|
| Symposium |
New Kids on the Block: Novel Neuropeptides in Reproductive Axis Regulation |
| |
Harnessing Metabolism in Cardiovascular Disease for Better Therapeutic Outcomes |
| |
Infertility: Genetics and Epigenetics of Disease with Clinical Implications |
| |
When to Stop Imaging in Pituitary Adenomas? |
| |
Addressing the Impact of Structural Racism on Endocrinology and Health Care |
| 12:15-2:15 PM |
|
| Professional Development |
Tackling Burnout and Achieving Life Balance |
| 2:00-3:00 PM |
|
| Special Scientific |
Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline |
| Oral Abstract |
What’s New in Weight Management Through the Lifespan? |
|
Novel Treatments for Metabolic Bone Diseases |
| |
Novel Molecular Insights in to Cardiovascular and Metabolic Disease |
| |
Tools and Mechanisms of Regulation in the Anterior Pituitary |
| |
Thyroid Hormone Metabolism and Action |
| 3:15-4:00 PM |
|
| Meet the Professor |
Management of Hormone Replacement in Post-Reproductive-Aged Women |
| |
Insulin Resistance: What Do Clinicians Need to Know in 2021? |
| |
A Little Help From My Friends: The Endocrinology-Psychiatry Interface — How Do We Help Each Other? |
| 3:15-4:45 PM |
|
| Symposium |
Pharmacogenomics of Hormone Receptor Signaling |
| |
How to Optimize Cardiovascular Health in Patients With Pituitary Tumors? |
| |
Putting the Pieces Together - Frontiers in Tissue Regeneration and Organ Replacement |
| 5:30-7:00 PM |
|
| Ancillary Symposia |
Rare Genetic Obesity: Analyzing the Role of Genetics in Obesity |
| |
A New Path Forward? Where Are We Going in Managing Hypoparathyroidism? |
